These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 565757)

  • 21. [Discussions regarding the reconstruction of the significance of leprosy in the post-sulfone period, Minas Gerais, in the 1950s].
    Carvalho KA
    Hist Cienc Saude Manguinhos; 2015; 22(2):541-58. PubMed ID: 26038861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early diagnosis, therapy, and research in the control of leprosy].
    Contreras Duenas F
    Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
    [No Abstract]   [Full Text] [Related]  

  • 23. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanism of action of sulfones in leprosy; activity of monoisopropyl sulfone and diisopropyl sulfone administered by mouth].
    DEHEZ F; FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(400):1-8. PubMed ID: 13395621
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
    Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
    Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
    [No Abstract]   [Full Text] [Related]  

  • 26. A 20-year study of the leprosy control programme at the Government Leprosy Treatment and Study Centre at Tirukoilur in south India.
    Radhakrishna S; Christian M; Nair NG
    Indian J Med Res; 1982 Jul; 76():18-35. PubMed ID: 7174008
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of leprosy.
    Crawford CL
    Lancet; 1971 Dec; 2(7738):1375. PubMed ID: 4108289
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current therapeutics in leprosy: resistance--therapeutic regimens--control strategy].
    Nebout M
    Acta Leprol; 1983; 1(3):151-8. PubMed ID: 6359803
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic activities of monoisopropyl sulfone and diisopropyl sulfone in leprosy].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(401):1-6. PubMed ID: 13395622
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of leprosy for control programmes.
    World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990
    [No Abstract]   [Full Text] [Related]  

  • 31. The histoid leproma. Its characteristics and significance.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1969; 37(1):1-21. PubMed ID: 5817631
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sulfone-resistance of Hansen's bacillus].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1957 Jul; 18(429):1-9. PubMed ID: 13560035
    [No Abstract]   [Full Text] [Related]  

  • 33. [Phenomenon in sulfone resistance in antileprotic therapy].
    FLOCH H
    Arq Min Leprol; 1957 Jul; 17(3):281-90. PubMed ID: 13522477
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of modern therapy of leprosy].
    Schuppli R
    Hautarzt; 1969 Mar; 20(3):116-8. PubMed ID: 5355958
    [No Abstract]   [Full Text] [Related]  

  • 35. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 36. The need for new drugs in the treatment and control of leprosy.
    Baker RJ
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):78-97. PubMed ID: 2181046
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanism of action of sulfones in leprosy. XI. Mechanism of action of intramuscular monoethyl sulfone].
    FLOCH H; FAURAN P; MAILLOUX M
    Publ Inst Pasteur Guyane Fr Inini; 1957 May; 18(424):1-12. PubMed ID: 13522261
    [No Abstract]   [Full Text] [Related]  

  • 38. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 39. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 40. Integration of leprosy control into the health centre scheme.
    Schaller KF
    Lepr Rev; 1969 Oct; 40(4):243-8. PubMed ID: 5385251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.